Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie’s $21 billion deal for Pharmacyclics — a sign of ‘desperation'?
AbbVie’s $21 billion deal for Pharmacyclics — a sign of ‘desperation'?
AbbVie’s $21 billion deal for Pharmacyclics — a sign of ‘desperation'?
Submitted by
admin
on March 5, 2015 - 5:58pm
Source:
Fortune
News Tags:
AbbVie
Pharmacyclics
M&A
Headline:
AbbVie’s $21 billion deal for Pharmacyclics — a sign of ‘desperation'?
Do Not Allow Advertisers to Use My Personal information
